Newsroom

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Western District of Texas, captioned Annonio v. New Era Energy & Digital, Inc., et al., Case No. 7:26-cv-00120, on behalf of persons and entities that purchased or otherwise acquired New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ: NUAI) f/k/a New Era Helium Inc. securities between November 6, 2024...

MILL VALLEY, Calif.--(BUSINESS WIRE)--Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a Chili's property for $2.3 million. The property is located in a strong, highly trafficked retail corridor in Illinois and corporate-operated under a triple net lease with approximately six years of term rem...

MANSFIELD, Mass.--(BUSINESS WIRE)--Copper Beech Wealth Management today announced it will no longer accept new full‑service wealth management clients as the firm transitions to a more specialized operating structure. The shift is designed to allow each business line to operate independently, enabling greater focus and alignment with evolving client needs. As part of the restructuring, Copper Beech is forming two standalone businesses: Copper Beech Financial Planning and Copper Beech Asset Manag...

PHILADELPHIA--(BUSINESS WIRE)--FORE Biotherapeutics, a registration stage company dedicated to developing targeted therapies to treat patients with cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to plixorafenib for the treatment of adult patients with BRAF V600E-mutated high-grade glioma (HGG). Fore Bio believes this is the first BTD granted to a targeted therapy for HGG. Plixorafenib is a novel BRAF inhibitor that is...

HOUSTON--(BUSINESS WIRE)--Expro Group Holdings N.V. (NYSE: XPRO) (the “Company” or “Expro”) today announced the Company’s Board of Directors (the “Board”) has unanimously approved a plan to change the Company’s corporate domicile from the Netherlands to the Cayman Islands (the “Redomicile”). The Company and the Board believe that the Redomicile will promote the sustainable success of its business, taking into account the interests of its shareholders and other stakeholders, and will enhance sha...

LONDEN--(BUSINESS WIRE)--The AI Summit London, de conferentie waar commerciële AI tot leven komt, heeft strategische samenwerkingen aangekondigd met de London Business School en General Purpose om twee specifieke AI Training-programma's voor te stellen, die op 9 juni doorgaan in aanloop op de conferentie. Gebaseerd op de wereldwijd erkende expertise in opleidingen voor executives van de DSAI (Data Science & AI Initiative) aan de London Business School, is de eendaagse AI Leadership Accelera...

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “aa-” (Superior) of the members of Metropolitan Life Insurance Group (collectively referred to as MetLife or the group). Concurrently, AM Best has affirmed the Long-Term ICR of “a-” (Excellent) and the Long- and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of MetLife, Inc. (headquartered in New York, NY) [NYSE: MET]...

TORONTO--(BUSINESS WIRE)--RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced that it is scheduled to release its financial and operational results for the three months ended March 31, 2026, after the market closes on Monday, May 4, 2026. Interested parties are invited to participate in a conference call with management on Tuesday, May 5, 2026 at 10:00 a.m. Eastern time. To access the conference call, participants are encouraged to pre‑register using the Pre-registratio...

MINNEAPOLIS--(BUSINESS WIRE)--On Thursday, April 30, 2026, Xcel Energy (NASDAQ: XEL) will host a conference call to review first quarter 2026 financial results. The earnings report will be released prior to the market open on the same date. The call will begin at 9:00 a.m. Central Time. To participate in the conference call, please dial in at least 10 minutes prior to the scheduled start and follow the operator’s instructions. U.S. Toll-Free Dial-In: 1-800-715-9871 U.S. / International Toll Dia...

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), een internationaal biotechnologiebedrijf dat R&D bevordert voor nieuwe geneesmiddelen op basis van antilichamen met innovatieve technologieën, kondigde vandaag een strategisch partnerschap aan met Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). In het kader van de overeenkomst zullen beide partijen het toonaangevende platform van Biocytogen voor de...